← Browse by Condition
Medical Condition

thyroid carcinoma anaplastic

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2, Phase 3
NCT05768178 Phase 2, Phase 3
Recruiting

DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.

Enrollment
30 pts
Location
United Kingdom
Sponsor
Cancer Research UK
View Trial →